<SEC-DOCUMENT>0001193125-25-167131.txt : 20250729
<SEC-HEADER>0001193125-25-167131.hdr.sgml : 20250729
<ACCEPTANCE-DATETIME>20250729070146
ACCESSION NUMBER:		0001193125-25-167131
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250729
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250729
DATE AS OF CHANGE:		20250729

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bausch Health Companies Inc.
		CENTRAL INDEX KEY:			0000885590
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14956
		FILM NUMBER:		251157497

	BUSINESS ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8
		BUSINESS PHONE:		514-744-6792

	MAIL ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Valeant Pharmaceuticals International, Inc.
		DATE OF NAME CHANGE:	20100928

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL Corp
		DATE OF NAME CHANGE:	20100416

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL CORP INTERNATIONAL
		DATE OF NAME CHANGE:	19960522
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d943437d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bhc="http://www.bauschhealth.com/20250729" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2025-07-29_to_2025-07-29" name="dei:EntityCentralIndexKey" contextRef="duration_2025-07-29_to_2025-07-29">0000885590</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2025-07-29_to_2025-07-29" name="dei:AmendmentFlag" contextRef="duration_2025-07-29_to_2025-07-29">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="bhc-20250729.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-07-29_to_2025-07-29"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885590</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-07-29</xbrli:startDate> <xbrli:endDate>2025-07-29</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_1">8-K</ix:nonNumeric></span></p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p><p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of the earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-07-29_to_2025-07-29" format="ixt:date-monthname-day-year-en" id="Fact_0">July 29, 2025</ix:nonNumeric></p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:EntityRegistrantName" id="ixv-246">Bausch Health Companies Inc.</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="ixv-247">British Columbia</ix:nonNumeric>, Canada</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:EntityFileNumber" id="ixv-248">001-14956</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:EntityTaxIdentificationNumber" id="ixv-249">98-0448205</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction of</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Incorporation or Organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(I.R.S. Employer<br/>Identification Number)</span></td></tr> </table><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:EntityAddressAddressLine1" id="ixv-250">2150 St. Elz&#233;ar Blvd. West</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:EntityAddressCityOrTown" id="ixv-251">Laval</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="ixv-252">Quebec</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2025-07-29_to_2025-07-29" format="ixt-sec:countrynameen" id="Fact_2">Canada</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_3">H7L&#160;4A8</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) (Zip Code)</p><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_4">514</ix:nonNumeric>) <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_5">744-6792</ix:nonNumeric></span></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="margin-top:8pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="ixv-257">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="ixv-258">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-07-29_to_2025-07-29" format="ixt-sec:boolballotbox" id="Fact_7">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="ixv-260">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p><p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_8">Common Shares, No Par Value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_9">BHC</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-07-29_to_2025-07-29" format="ixt-sec:exchnameen" id="Fact_10">New York Stock Exchange</ix:nonNumeric>, Toronto Stock Exchange</td></tr> </table><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric contextRef="duration_2025-07-29_to_2025-07-29" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="ixv-264">&#9744;</ix:nonNumeric></p><p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events</p></td></tr> </table><p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;29, 2025, Bausch Health Companies Inc. (&#8220;BHC&#8221;) and DURECT Corporation (&#8220;DURECT&#8221;) issued a joint press release announcing the execution of an Agreement and Plan of&#160;Merger&#160;(the &#8220;Merger&#160;Agreement&#8221;). Pursuant to the&#160;Merger&#160;Agreement, BHC Lyon Merger Sub, Inc., a wholly-owned subsidiary of BHC (&#8220;BHC Lyon&#8221;), will commence a&#160;tender offer&#160;(the &#8220;Offer&#8221;) to purchase all of the issued and outstanding shares of common stock of DURECT, for (a) $1.75 per share in cash, <span style="font-style:italic">plus</span> (b)&#160;one <span style="white-space:nowrap">non-transferrable&#160;contingent</span> value right&#160;for each share of DURECT common stock, which represents the contractual right to receive the <span style="font-style:italic">pro rata</span> portion of two milestone payments of up to $350,000,000 in the aggregate (net of retention bonuses payable to certain DURECT employees upon milestone achievement) upon the achievement of net sales milestones. If successful, the Offer will be followed by a&#160;merger&#160;of BHC Lyon with and into DURECT. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Additional Information</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The tender offer described in this communication has not yet commenced. This communication is neither an offer to purchase nor a solicitation of an offer to sell shares of the common stock of DURECT or any other securities. At the time the tender offer is commenced, we will file, or will cause to be filed, tender offer materials on Schedule TO with the SEC and DURECT will file a Solicitation/Recommendation Statement on Schedule <span style="white-space:nowrap">14D-9</span> with the SEC, in each case with respect to the tender offer. <span style="font-weight:bold">THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND OTHER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT, AS THEY MAY BE AMENDED FROM TIME TO TIME, WILL CONTAIN IMPORTANT INFORMATION THAT SHOULD BE READ CAREFULLY WHEN THEY BECOME AVAILABLE AND CONSIDERED BEFORE ANY DECISION IS MADE WITH RESPECT TO THE TENDER OFFER.</span> Those materials and all other documents filed by, or caused to be filed by, BHC and DURECT with the SEC will be available at no charge on the SEC&#8217;s website at www.sec.gov. The tender offer materials and related materials also may be obtained for free (when available) under the &#8220;Corporate Governance&#8212;SEC Filings&#8221; section of our investor website at https://ir.bauschhealth.com/, and the Solicitation/Recommendation Statement and such other documents also may be obtained for free (when available) from DURECT under the &#8220;SEC Filings&#8221; section of DURECT&#8217;s investor website at https://www.durect.com/investors/.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Exhibits</p></td></tr> </table><p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p><p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d943437dex991.htm">Joint Press Release, dated July&#160;29, 2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (formatted as Inline XBRL).</td></tr> </table></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Signatures</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0">
<tr>
<td style="width:13%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:86%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">BAUSCH HEALTH COMPANIES INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jean-Jacques Charhon</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Jean-Jacques Charhon</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, Chief Financial Officer</td></tr></table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: July&#160;29, 2025</p></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d943437dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g943437dsp005.jpg" ALT="LOGO" STYLE="width:2.69583in;height:0.306944in;">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g943437dsp005a.jpg" ALT="LOGO" STYLE="width:1.34236in;height:0.529861in;">
</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Investor Contact:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Media Contact:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Garen Sarafian</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Katie Savastano</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>ir@bauschhealth.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>corporate.communications@bauschhealth.com</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">877-281-6642</FONT></FONT> (toll-free)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(908) <FONT STYLE="white-space:nowrap">569-3692</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Investor Relations (DURECT Corporation)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Media Contact (DURECT Corporation)</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sandya von der Weid</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Michael Fitzhugh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">LifeSci Advisors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">LifeSci Communications</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>svonderweid@lifesciadvisors.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>mfitzhugh@lifescicomms.com</U></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Innovative Solutions for Patients with Liver Disease </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>DURECT&#146;s lead asset, </I></B><B><I>Larsucosterol</I></B><B><I>, is </I></B><B><I>an epigenetic
modulator </I></B><B><I>with FDA Breakthrough Therapy Designation </I></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Potential to be the first <FONT STYLE="white-space:nowrap">FDA-approved</FONT> therapeutic option for the
treatment of patients with alcoholic hepatitis</I></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Proposed acquisition strengthens Bausch Health&#146;s commitment to hepatology and patients suffering with
liver disease complications globally</I></B> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LAVAL, Quebec and CUPERTINO, California, July&nbsp;29, 2025 &#150; Bausch Health Companies
Inc. (NYSE: BHC) (TSX: BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ: DRRX) today announced a definitive agreement under which Bausch Health will indirectly acquire DURECT Corporation, including a novel
therapeutic molecule, larsucosterol, which can harness the power of epigenetic modulation. Larsucosterol, an endogenous sulfated oxysterol and an epigenetic modulator, has demonstrated promising results for the treatment of alcoholic hepatitis (AH)
in Phase 2 trials. Bausch Health&#146;s hepatology development and commercial capabilities are well-suited to support the clinical development and potential commercialization of larsucosterol. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AH is a life-threatening form of alcohol-associated liver disease (ALD), which can occur in individuals who chronically misuse alcohol. It is characterized by
severe inflammation and destruction of liver tissue (i.e., necrosis). AH accounted for roughly 164,000 hospital admissions in the U.S. in 2021. There is currently no Food and Drug Administration (FDA) or European Medicines Agency (EMA) approved
treatment for AH, and novel therapeutic strategies are needed to improve patient survival. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;This announcement is fundamental progress on our
Strategic Priority&#151;Innovation, which is to intensify focus and operating rigor behind R&amp;D and business development and demonstrates our commitment to hepatology and finding new ways to address unmet medical needs, living our purpose of
enriching lives through our relentless drive to deliver better health outcomes for patients.&#148; said Thomas J. Appio, Chief Executive Officer, Bausch Health. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;There is a significant unmet need in the treatment of patients with AH given the high mortality rate
and that there are no currently approved treatments. We are very excited to add larsucosterol, an asset which has FDA Breakthrough Therapy Designation, to our pipeline, particularly as it builds on our existing expertise within the hepatology space.
It is complementary to our ongoing Phase 3 program of soluble solid dispersion of rifaximin (rifaximin SSD) being studied in cirrhotic patients globally,&#148; stated Jonathan Sadeh M.D., M.Sc. as Executive Vice President, Chief Medical Officer and
Head of R&amp;D at Bausch Health. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;AH, by our estimates, is responsible for about 100 deaths per day in the US and billions of dollars in healthcare
costs,&#148; stated James E. Brown, D.V.M., President and CEO of DURECT. &#147;Since we reported results from our Phase 2b AHFIRM clinical trial for larsucosterol in AH, our primary focus has been advancing larsucosterol towards the completion of
clinical development. We chose this transaction with Bausch Health because we believe it provides significant value for our stakeholders, both immediately and in the long term, should larsucosterol be approved and achieve commercial success. We view
Bausch Health as the right partner to advance larsucosterol due to their expertise in hepatology, commercial success with Xifaxan and experienced development team. We look forward to the potential impact larsucosterol could have for patients with AH
and the medical community that cares for them. Thank you to our team at DURECT and our partners that have helped advance larsucosterol to this point.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A registrational Phase 3 program to evaluate the safety and efficacy of larsucosterol for the treatment of patients with severe AH is being planned. The trial
will be a randomized, double-blind, placebo-controlled, multi-center study. The primary endpoint will be <FONT STYLE="white-space:nowrap">90-day</FONT> survival. The trial design will incorporate feedback received from the FDA during a Type B
meeting under Breakthrough Therapy Designation as well as learnings from the prior Phase&nbsp;2b&nbsp;AHFIRM trial in AH. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The acquisition of the clinical
development program for larsucosterol in AH compliments the ongoing Bausch Health <FONT STYLE="white-space:nowrap">RED-C</FONT> clinical program which is designed to assess the efficacy of a next generation therapeutic, rifaximin SSD, to delay onset
of first overt hepatic encephalopathy (OHE) hospitalization and <FONT STYLE="white-space:nowrap">all-cause</FONT> mortality. There are no medications globally approved for the primary prophylaxis and delay in decompensation to first episode of OHE
in cirrhosis. Patient enrollment in two global Phase 3, randomized, double-blind, placebo-controlled studies is now complete with efficacy and safety results expected to be announced in early 2026. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The addition of larsucosterol to our pipeline is a strategic fit with our focus in hepatology and underscores our continued dedication to exploring and
identifying new treatments for individuals who are suffering with liver disease and its complications,&#148; stated Aimee Lenar, Executive Vice President of US Pharma at Bausch Health. &#147;We are excited to continue investment in bringing these
breakthrough options to market, not just in the US, but also globally.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transaction Terms and Financial Considerations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the definitive agreement, a wholly owned subsidiary of Bausch Health will commence a tender offer for all outstanding shares of DURECT
Corporation. Under the terms of the definitive agreement, Bausch Health will pay $1.75 per share in an <FONT STYLE="white-space:nowrap">all-cash</FONT> transaction for an upfront consideration of approximately $63&nbsp;million at closing, with the
potential for two additional net sales milestone payments of up to $350&nbsp;million in the aggregate (subject to certain adjustments in respect of a retention plan) if the milestone is achieved before the earlier of the 10 year anniversary of the
first commercial sale in the United States and December&nbsp;31, 2045. The purchase price payable at closing represents a premium of approximately 191% to the <FONT STYLE="white-space:nowrap">30-day</FONT> volume-weighted average trading price of
DURECT&#146;s common stock ended on July&nbsp;28, 2025, the last trading day before the announcement of the transaction. This upfront consideration represents a premium of approximately 217% to the trading price of DURECT&#146;s common stock ended
on July&nbsp;28, 2025. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction is conditioned on a majority of the outstanding shares of DURECT Corporation&#146;s common
stock being tendered into the tender offer and not withdrawn, as well as other customary closing conditions. The transaction is expected to close in the third quarter of 2025. Assuming the closing of the tender offer, Bausch Health will acquire any
shares of DURECT not tendered into the tender offer through a merger of a wholly owned subsidiary with and into DURECT for the same per share consideration payable in the tender offer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advisors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Centerview Partners LLC is serving as exclusive
financial advisor and Sullivan&nbsp;&amp; Cromwell LLP is serving as legal advisor to Bausch Health. Locust Walk is serving as exclusive financial advisor and Orrick, Herington and Sutcliffe LLP is serving as legal advisor to DURECT. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Bausch Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bausch Health Companies Inc. (NYSE:
BHC) (TSX: BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology,
neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by
patients, HCPs, employees and investors. Our gastroenterology business, Salix Pharmaceuticals, is one of the largest specialty pharmaceutical businesses in the world and has licensed, developed and marketed innovative products for the treatment of
gastrointestinal diseases for more than 30 years. For more information about Salix, visit&nbsp;<U>www.Salix.com</U>&nbsp;and connect with us on <U>Twitter</U><U></U>&nbsp;and&nbsp;<U>LinkedIn</U>. For more information about Bausch Health,
visit&nbsp;<U>www.bauschhealth.com</U>&nbsp;and connect with us on&nbsp;<U>LinkedIn</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About DURECT Corporation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DURECT Corporation (Nasdaq: DRRX) is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated DNA
methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. Larsucosterol, DURECT&#146;s lead drug candidate, binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that
are elevated and associated with hypermethylation found in AH patients. Larsucosterol is in clinical development for the potential treatment of AH, for which the FDA has granted a Fast Track and a Breakthrough Therapy designation; MASH is also being
explored. For more information about DURECT, please visit <U>www.durect.com</U> and follow us on X (formerly Twitter) at <U>https://x.com/DURECTCorp</U>.<B> </B> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release may contain forward-looking statements about the proposed transaction with DURECT (the &#147;Transaction&#148;) and the future performance of
Bausch Health (Bausch Health and DURECT, collectively, &#147;the Parties&#148;), which may generally be identified by the use of the words &#147;anticipates,&#148; &#147;hopes,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;plans,&#148;
&#147;should,&#148; &#147;could,&#148; &#147;would,&#148; &#147;may,&#148; &#147;believes,&#148; &#147;subject to&#148; and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are
subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to the
Parties&#146; overall businesses, including those more fully described in the Parties&#146; most recent annual reports on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and detailed from time to time in the Parties&#146; other filings with the
U.S. Securities and Exchange Commission and, in the case of Bausch Health, the Canadian Securities Administrators, which factors are incorporated herein by reference. In addition, such risks and uncertainties include, but are not limited to, the
following: uncertainties relating to the timing of the consummation of the proposed Transaction; the possibility that any or all of the conditions to the consummation of the Transaction may not be satisfied or waived; the failure to obtain requisite
stockholder approval of DURECT, the effect of the announcement or pendency of the Transaction on Parties&#146; ability to maintain relationships with customers, suppliers, and other business partners; the impact of the Transaction if consummated on
Bausch&#146;s business, financial position and results of operations, including with respect to expectations regarding margin expansion, accretion and deleveraging; and risks relating to potential diversion of management attention away from the
Parties&#146; ongoing business operations. There can be no assurance that the conditions to closing the Transaction will be satisfied or that the tender offer and the Transaction will be consummated. Additional information regarding certain of these
material factors and assumptions may be found in the Parties&#146; filings described above as well as the filings made in connection with the Transaction described below. These forward-looking statements speak only as of the date hereof. The Parties
undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release is for
information purposes only and not intended to be a recommendation to buy, sell or hold securities and does not constitute an offer for the sale of, or the solicitation of an offer to buy, securities in any jurisdiction, including the United States.
At the time the tender offer is commenced, we will file, or will cause to be filed, tender offer materials on Schedule TO with the SEC and DURECT will file a Solicitation/Recommendation Statement on Schedule
<FONT STYLE="white-space:nowrap">14D-9</FONT> with the SEC, in each case with respect to the tender offer. <B>THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND OTHER OFFER DOCUMENTS) AND THE
SOLICITATION/RECOMMENDATION STATEMENT, AS THEY MAY BE AMENDED FROM TIME TO TIME, WILL CONTAIN IMPORTANT INFORMATION THAT SHOULD BE READ CAREFULLY WHEN THEY BECOME AVAILABLE AND CONSIDERED BEFORE ANY DECISION IS MADE WITH RESPECT TO THE TENDER
OFFER.</B> Those materials and all other documents filed by, or caused to be filed by, BHC and DURECT with the SEC will be available at no charge on the SEC&#146;s website at www.sec.gov. The tender offer materials and related materials also may be
obtained for free (when available) under the &#147;Corporate Governance&#151;SEC Filings&#148; section of our investor website at https://ir.bauschhealth.com/, and the Solicitation/Recommendation Statement and such other documents also may be
obtained for free (when available) from DURECT under the &#147;SEC Filings&#148; section of DURECT&#146;s investor website at https://www.durect.com/investors/. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bhc-20250729.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 7/28/2025 3:41:21 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:bhc="http://www.bauschhealth.com/20250729"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:us-types="http://fasb.org/us-types/2024"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.bauschhealth.com/20250729"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhc-20250729_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhc-20250729_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>bhc-20250729_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 7/28/2025 3:41:09 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 1</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>bhc-20250729_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 7/28/2025 3:40:58 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="bhc-20250729.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.331" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="31.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g943437dsp005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g943437dsp005.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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ME3WL$4G]UY #^5<D:<Y*Z1Z$JU.#M*23+*LKJ&4@@\@CO4;&B:>QX/\ %O\
MY'<_]>L?\VIH&6[+XM3V.B6^G+HT#^1 L(>24D-@8R1C],T6"YE?#?3HM1\9
MVLTMU#!]G;SEB)PTC#. H]NOTH!'8_&/6O*LK+18F^:9O/E _NCA1^)R?PH0
M,X74O"LECX%TK72K;KF5A(/13]S^1_,4"/1?"&M?VK\*]0MY&S/8VTL#9Z[=
MA*G\N/PH&<!\,?\ D?M-^DG_ *+:A@CT'XR?\BK9_P#7XO\ Z U"!G*^!=)G
MUOP+XHT^VQY\IB* G )&2!^.,4 CF]%UO5_ VL2R+:"*X*^7)%<QD9&<^Q[=
MJ!;&]<^-] \17\5QXE\.;Y%79YUM<,"%S_=XS^= R]\1WT^#PEX=M=%;_B5R
M-)+&-Q/IZ\]6-"!FS\(-'LFT*YU.2WCDN7G,8=E!*J .!Z<DT,$7/%_PT@U_
M54O;.Z@T\E-LJ^5D.<_>X(YH P?&NB2^'?AEI^F2W:W7E7V5=5VC!#G&,GUH
M Y7PIXYO?"-M<P6MI!.L[AR92>,#':@-B76];F\;W,=[>Q);/;KY2K#D@C.<
MG->E@\'&O%ML\7,<QGA)J,5>Z-'3?B7J/AK3H='M[&VEAM1M5Y"VXY.><'WK
MDKTE2J."Z'H82NZ]&-1K<]?\-:I+K?ARQU*:-8Y+B/>RIT'/;-<YUG#VNOVN
M@>-=<FNHY765RH\L G.<]S7N2P\J^&IJ+V/EX8N&%QM5S3U[&R_Q'TEHV46U
MWR,?<7_&N99;575':\YH6MRO[C+\*ZD=(\#:I>H 728[ ?[Q"@?SK?%TO:XF
M$/(Y,!7]A@JE1=R?0=%T6[LDU'7+R&ZO;D;V$LX&P'H,9ZUG7K5H2Y**LEY&
MN$PV'J0]KB))R?=D&H"S\*:U97^BW:&UF?9<6Z2AQCUZ_P"<55/GQ5.4*JU6
MS,ZOL\#6C4H2]UZ-7-WQ)I>IZWJEG9@M'HX&Z>17 +'GC'X#\ZY<-5IT82E]
MKH=^-H5L34C#:GU*VH:'X+M;)XYFMX&"\,LV7!_/DU=.OBY2NKLSJX7+X0:=
ME\]2KX9OIKOP'JT4TC2"W21$9NNW9D"M,53C#$Q:ZV,<%5E4P512=[7)/#&B
M66N>";2&^1F2.9W4*VWG)%&*K3HXEN!6!PU/$X*,:G1LS/"'A;2]:L[R2\CD
M9HIS&NUR.,"M\9BJM*45%[HY<NP%&O&3FMF6_&<$L6O>'[>Q.R51Y<1/.TY
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8;B=W.:UE5G.*C)Z(PIX>G2FYQ6KW/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g943437dsp005a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g943437dsp005a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /?Z "@!&8(I9B H&23VH$VDKLYB;Q>9[IK?2;%[PKU<9Q^
M':IFW'9'B2S;VDW##0YO,DA\3SP2K'JFG/;!NC#./R-<4L9[)VJ1LCHACIIV
MK0Y3HHW22-71@R,,@CN*[HR4E=;'IIIJZ'4QA0 4 % !0 4 % !0 4 % !0
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M-NR$9L/B30[BX^SPZS8R39QL6X0MGZ9K>6%KQ7,X.WHQ\K70U*YQ$-S=VUE
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M?YUZTL1E59\\X-/^NQI>#U-;PK\.;NVUT>(O%.I?VGJR\Q@9*1GL><9([
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M >E<^.>#;3PJ:[W%+E^R=37GD!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 29,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Bausch Health Companies Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">A1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-14956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0448205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">2150 St. Elz&#233;ar Blvd. West<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Laval<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">QC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">H7L&#160;4A8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">744-6792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Shares, No Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BHC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d943437d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>bhc-20250729.xsd</File>
    <File>bhc-20250729_lab.xml</File>
    <File>bhc-20250729_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d943437d8k.htm">d943437d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d943437d8k.htm": {
   "nsprefix": "bhc",
   "nsuri": "http://www.bauschhealth.com/20250729",
   "dts": {
    "schema": {
     "local": [
      "bhc-20250729.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "bhc-20250729_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bhc-20250729_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d943437d8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-07-29_to_2025-07-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d943437d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-07-29_to_2025-07-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d943437d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "terseLabel": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Country",
        "terseLabel": "Entity Address Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.bauschhealth.com//20250729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-25-167131-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-167131-xbrl.zip
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M^/+-%^"%QS[@9K4.1ZZ8[<8M3JMZ53U,-IMX<5)O]O*HG#=V^Q=02P,$%
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M\V-Q[8GJBVG/J,7S/[Q^<A64DG&G"\R[KILCYLN\N:E+_@%02P,$%     @
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M'D[SKV(YGP$'A_\AA^7IF#N0N3L,>-(.DR$P9W@?$0XY=!T(:02.)#T$#&&
MT:/0-228J1/: !-XT&$^.7#'8O=2EH]4FYQL_A9GP@D%A2[SCB)+($ 3@6&
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M              "  ;,)  !B:&,M,C R-3 W,CE?<')E+GAM;%!+ 0(4 Q0
M   ( #8X_5IJ7#?+W1(  *UG   .              "  8T.  !D.30S-#,W
M9#AK+FAT;5!+ 0(4 Q0    ( #8X_5HC;6Q/0QH  &E7   1
M  "  98A  !D.30S-#,W9&5X.3DQ+FAT;5!+!08     !0 % #T!   (/
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d943437d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bhc-20250729.xsd" xlink:type="simple"/>
    <context id="duration_2025-07-29_to_2025-07-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885590</identifier>
        </entity>
        <period>
            <startDate>2025-07-29</startDate>
            <endDate>2025-07-29</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-07-29_to_2025-07-29"
      id="Hidden_dei_EntityCentralIndexKey_duration_2025-07-29_to_2025-07-29">0000885590</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2025-07-29_to_2025-07-29"
      id="Hidden_dei_AmendmentFlag_duration_2025-07-29_to_2025-07-29">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_0">2025-07-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-246">Bausch Health Companies Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-247">A1</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-248">001-14956</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-249">98-0448205</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-250">2150 St. Elz&#xe9;ar Blvd. West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-251">Laval</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-252">QC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_2">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_3">H7L&#160;4A8</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_4">514</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_5">744-6792</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-257">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-258">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_7">true</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-260">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_8">Common Shares, No Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_9">BHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-07-29_to_2025-07-29" id="Fact_10">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-07-29_to_2025-07-29" id="ixv-264">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
